Goldman Sachs sharply cuts Alignment Healthcare price target
The large target reduction is a negative analyst revision, though the new target still implies upside from the posted price.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The large target reduction is a negative analyst revision, though the new target still implies upside from the posted price.
What happened, with direct paths to the underlying reporting
Goldman Sachs lowered its ALHC target to $12 from $25, a steep reduction. The new target remains above the posted price of $8.44, so this is a bearish revision rather than a below-market target.
Target: $12
Posted price: $8.44
Analyst firm: Goldman Sachs
Analyst: Scott Fidel
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.